Destiny Pharma PLC
F:D89
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Destiny Pharma PLC
F:D89
|
UK |
|
O
|
Observe Medical ASA
F:OM5A
|
NO |
|
B
|
Boryszew SA
XMUN:BOW
|
PL |
|
Boryszew SA
F:BOW
|
PL |
|
Delta Drone International Ltd
ASX:DLT
|
AU |
|
C
|
Cohiba Minerals Ltd
OTC:CHKMF
|
AU |
|
F
|
Futebol Clube do Porto Futebol Sad
XMUN:FBC
|
PT |
|
Q
|
Qingco Inc
OTC:QING
|
CN |
|
C
|
CHAR Technologies Ltd
OTC:CTRNF
|
CA |
|
W
|
Westag AG
XMUN:WUG3
|
DE |
|
Castellum AB
F:TEX
|
SE |
|
L
|
Likewise Group PLC
F:7RL
|
UK |
|
La Francaise des Jeux SA
F:1WE
|
FR |
|
Okea ASA
F:3SX
|
NO |
|
O
|
Odfjell SE
SWB:O7F
|
NO |
|
Kraft Bank ASA
F:709
|
NO |
|
W
|
Wereldhave NV
F:WER
|
NL |
|
Orbis Se
F:OBS
|
DE |
|
Bhakti Agung Propertindo Tbk PT
IDX:BAPI
|
ID |
|
Compagnie des Alpes SA
F:JCA
|
FR |
|
E
|
Etablissements Maurel et Prom SA
SWB:ETX
|
FR |
|
Etruscus Resources Corp
F:ERR
|
CA |
|
Nyfosa AB
F:2JM
|
SE |
|
Astra Agro Lestari Tbk PT
OTC:PTABF
|
ID |
Bankruptcy Probability
Destiny Pharma PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Destiny Pharma PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Destiny Pharma PLC
LSE:DEST
|
2.9m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
440.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
224.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
65.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Destiny Pharma PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Destiny Pharma PLC has no debt.
You can find a full breakdown on its Balance Sheet.
